Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining Challenges
- PMID: 38990395
- DOI: 10.1007/s11046-024-00861-2
Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining Challenges
Abstract
Since its inception in 2002, the EUCAST Antifungal Susceptibility Testing Subcommittee (AFST) has developed and refined susceptibility testing methods for yeast, moulds and dermatophytes, and established epidemiological cut-off values and breakpoints for antifungals. For yeast, three challenges have been addressed. Interpretation of trailing growth in fluconazole susceptibility testing, which has been proven without impact on efficacy if below the 50% endpoint. Variability in rezafungin MIC testing due to laboratory conditions, which has been solved by the addition of Tween 20 to the growth medium in E.Def 7.4. And third, interpretation of MICs for rare yeast with no breakpoints, where recommendations have been established for MIC-based clinical advice. For moulds, refinements include the validation of spectrophotometer reading for A. fumigatus to facilitate objective MIC determination, and for dermatophytes the establishment of a microdilution method with automated reading and a selective medium to minimise the risk of contaminations. Recent initiatives involve development and validation of agar-based screening assays for detection of potential azole and echinocandin resistance in A. fumigatus and Aspergillus species, respectively, and of terbinafine resistance in Trichophyton species. Moreover, the development of a EUCAST guidance document for molecular resistance testing represents an advancement, particularly for identifying target gene alterations associated with resistance. In summary, EUCAST AFST continues to play a pivotal role in standardizing AFST and facilitating accurate interpretation of susceptibility data for clinical decision-making. Adoption of EUCAST breakpoints for commercial test methods, however, requires thorough validation to ensure concordance with EUCAST reference testing species-specific MIC distributions.
Keywords: Antifungal; Dermatophyte; Microdilution; Mould; Susceptibility testing; Yeast.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Cuenca-Estrella M, Moore CB, Barchiesi F, Bille J, Chryssanthou E, Denning DW, et al. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the antifungal susceptibility testing subcommittee of the european committee on antimicrobial susceptibility testing (AFST-EU. Clin Microbiol Infect. 2003;9:467–74. - DOI - PubMed
-
- Arendrup MC, Friberg N, Mares M, Kahlmeter G, Meletiadis J, Guinea J, et al. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2020;26:1464–72. - DOI - PubMed
-
- Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. 4th ed. CLSI standard M27. Clinical and Laboratory Standards Institute, Wayne, PA; 2017.
-
- Espinel-Ingroff A, Canton E, Peman J, Rinaldi MG, Fothergill AW. Comparison of 24-hour and 48-hour voriconazole MICs as determined by the clinical and laboratory standards institute broth microdilution method (M27–A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and othe. J Clin Microbiol. 2009;47:2766–71. - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
